Outcomes from the part 3 VERONA trial had been offered on the 2025 Society of Hematologic Oncology Annual Assembly.Sufferers with revised worldwide prognostic scoring...
Your analysis of an early-stage blood most cancers, reminiscent of a myeloproliferative neoplasm (MPN) or a myelodysplastic syndrome (MDS), signifies that one thing...